Drugs

Postmarket Drug Safety Information for Patients and Providers

In accordance with Section 915 of the Food and Drug Administration Amendments Act of 2007 (FDAAA), this website contains links to postmarket drug safety information to improve transparency and communication to patients and healthcare providers. 

 

Studies and Clinical Trials of Approved Products

Latest Safety Information

General Health Information

  • MedlinePlus
    Authoritative drug and health information from the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Drug Labeling

Consumer Information

Page Last Updated: 09/08/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.